A Coming Health Danger Threatening the Lives of Tens of Millions.. Is the World Ready?

SadaNews - A very tough health dilemma awaits the world, represented in the fact that bacterial infections have become more resistant to antibiotics. Experts warn that this global health crisis could lead to the deaths of millions of people in the near future, according to medical researcher Phyllis Arthur.

The researcher added in an article on the American Hill website that according to a report published by the scientific journal "The Lancet," antibiotic resistance is expected to contribute to around 170 million deaths globally over the next 25 years.

According to Phyllis, the main problem lies in the fact that bacterial infections have become more resistant to treatment with traditional antibiotics, with estimates suggesting that one in every six bacterial infections is now resistant to antibiotics, complicating the treatment of many infectious diseases.

Trade

The writer clarified that this gap between rapidly evolving microbes and decreasing production lines of antibiotics could pave the way for greater health disasters in the future.

She stated that developing new antibiotics is the only solution, pointing out that this research faces several challenges.

For example, in 2024, work was underway to develop new antibiotics, but only five out of 90 were effective against pathogens classified by the World Health Organization as "critical priority."

Phyllis states that the lack of innovation and solutions is due to the economic constraints facing pharmaceutical companies in developing new antibiotics, as they are unable to achieve a real profit from their sales.

She clarified that the overuse of traditional antibiotics has led to increased bacterial resistance, as microbes adapt to drugs over time, making treatment more difficult.

Studies indicate that drug-resistant bacteria currently cause the deaths of over a million people annually worldwide.

According to some estimates, developing a single antibiotic can take over 10 years at a cost exceeding a billion dollars, while sales revenues can be negatively impacted by up to 50 million dollars.

As a result of these circumstances, major companies have withdrawn from the antibiotic development market, while smaller companies continue to struggle for survival.

Source: Hill